Researchers at the MTN include international investigators and community and industry partners who work together to evaluate promising microbicide products.
More than 25 clinical research sites on four continents have partnered with the Microbicide Trials Network in the conduct of its clinical trials.
Studies at the Microbicide Trials Network are designed specifically to support the potential licensure and regulatory approval of HIV prevention products for populations most vulnerable to HIV.
The Microbicide Trials Network brings together international investigators and community and industry partners whose work is focused on the rigorous evaluation of promising microbicides.
The Microbicide Trials Network is a U.S. National Institutes of Health-funded worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV.
Microbicide Trials Network Research Prominent at 2018 HIV R4P.
MTN is excited to announce the launch of MTN-037.
MTN-033 is launched.
MTN presented preliminary results from the HOPE study (MTN-025) at CROI 2018.
Presentations from the MTN 2018 Regional Meeting have been posted.
The stakeholders consultation meeting report for MTN-042 has been posted to our website.
The MTN 2018 Manual of Operational Procedures is posted to our website.
Women’s use of vaginal ring is higher in open-label study, as is level of HIV protection
HIV prevention dapivirine vaginal ring found safe and acceptable in US adolescent girls
U.S. study of dapivirine ring in lactating women finds little drug gets into breast milk
Microbicide Trials Network